Literature DB >> 2241107

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

G G Schwartz1, B S Hulka.   

Abstract

Prostate cancer is a major cause of cancer death among males, yet little is known about its etiology. We hypothesize that Vitamin (Hormone) D deficiency may underlie the major risks for prostate cancer, including age, Black race, and northern latitudes. These factors all are associated with decreased synthesis of Vitamin D. Mortality rates from prostate cancer in the U.S. are inversely correlated with ultraviolet radiation, the principal source of Vitamin D. This hypothesis is consistent with known antitumor properties of Vitamin D, and may suggest new avenues for research in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241107

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  93 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

Review 2.  [Chemoprevention of prostate cancer].

Authors:  B Djavan; I Thompson; M S Michel; M Waldert; C Seitz
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

3.  Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Vitamin d for the management of prostate cancer.

Authors:  Masood A Khan; Alan W Partin
Journal:  Rev Urol       Date:  2004

6.  Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.

Authors:  Jong-Wei Hsu; Sayeda Yasmin-Karim; Michael R King; Joel C Wojciechowski; Deanne Mickelsen; Martha L Blair; Huei-Ju Ting; Wen-Lung Ma; Yi-Fen Lee
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

7.  Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.

Authors:  Yong Xu; Fang Fang; Daret K St Clair; Sajni Josson; Pradoldej Sompol; Ivan Spasojevic; William H St Clair
Journal:  Mol Cancer Ther       Date:  2007-06-29       Impact factor: 6.261

8.  Duration of vitamin D synthesis from weather model data for use in prospective epidemiological studies.

Authors:  Kåre Edvardsen; Ola Engelsen; Magritt Brustad
Journal:  Int J Biometeorol       Date:  2009-05-15       Impact factor: 3.787

9.  Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.

Authors:  William B Grant
Journal:  Am J Pathol       Date:  2008-11       Impact factor: 4.307

10.  Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Authors:  M M Braun; K J Helzlsouer; B W Hollis; G W Comstock
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.